Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

National Institutes of Health Donates Protease Inhibitor Patent to UNITAID Medicines Patent Pool

Autumn 2010

On September 30, 2010 the U.S. National Institutes of Health (NIH) became the first research funder to license intellectual property rights to the Medicines Patent Pool essential to manufacturing anti-HIV protease inhibitors. The patent pool is an innovative initiative that -- by pooling patents from diverse inventors -- will allow the manufacture of low-cost, high-quality generic medications for people with HIV and other life-threatening diseases in low- and middle-income countries.

By becoming the first research funder to license medical patents to the Medicines Patent Pool, the NIH has taken a historic step toward facilitating equitable global access to medical innovations created with taxpayer funds to fight such diseases of global concern as HIV,

View Full Article


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

 
See Also
More on HIV Drug Patent Policies

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement